Skip to main content


Page 1 of 8

  1. Ectopic liver tissue (ELT) is a developmental abnormality in which liver tissue develops at an extrahepatic site without connection to the true liver. It is a rare entity with an incidence of 0.24–0.56% accord...

    Authors: Andrew Yesaya Swallow, Ali Hamisi Mwanga, Douglas Chamshama, Godfrey Mchele, Yona Ringo, Kibwana Kitembo, William Lutege, Azza Naif and Innocent Mosha
    Citation: Egyptian Liver Journal 2024 14:61
  2. Cirrhotic cardiomyopathy, an intricate and multifaceted complication of end-stage liver disease, manifests as systolic and diastolic dysfunction in patients without previously diagnosed cardiac disease. Our st...

    Authors: Hala Mansoor, Mahnam Khizer, Aneela Afreen, Noor Masood Sadiq, Aamir Habib, Shafqat Ali, Asim Raza and Tayyaba Hafeez
    Citation: Egyptian Liver Journal 2024 14:60
  3. Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE ...

    Authors: Mohamed Elbadry, Amin Abdel Baki, Asmaa bakr, Eman A. Elhamrawy, Hayam Abdel-Tawab, Abdelghany Aish, Israa Nooh, Abdulmoneim Adel, Moataz Y. Soliman, Nessren Mohammed and Samy Zaky
    Citation: Egyptian Liver Journal 2024 14:59
  4. Bouveret syndrome is a rare etiology of gastric outlet obstruction, presenting with clinical manifestations that resemble those of several gastric pathologies. Timely diagnosis is imperative to mitigate potent...

    Authors: Marya Hameed, Muhammad Fazal Hussain Qureshi and Fatima Siddiqui
    Citation: Egyptian Liver Journal 2024 14:58
  5. HCC (Hepatocellular carcinoma) is the most common primary malignant cancer in the liver. Treatment options to incurable HCC such as sorafenib, an oral multikinase inhibitor, had numerous side effects and quest...

    Authors: Heba E. Sedky, Yasmine N. Elwany, Eman S. El Alfy, Mona N. Elwany, Yasmin M. Nabil, Hazem F. Manna, Mohamed A. Abdelaziz and Wessam F. El Hadidy
    Citation: Egyptian Liver Journal 2024 14:57
  6. Hepatitis B virus (HBV) infection is a significant global public health threat with variable geographical distribution. Chronic infection with HBV could be complicated by chronic hepatitis state, progression t...

    Authors: Walaa Abdelhamed and Mohamed El-Kassas
    Citation: Egyptian Liver Journal 2024 14:56
  7. Hepatitis B virus (HBV) infection is one of the major public health problems worldwide. In pregnant women, there is a risk of mother-to-child transmission (vertical transmission) of the infection. The contamin...

    Authors: Rick-Leonid Ngoua Meye Misso, Joseph Privat Ondo, Cédric Sima Obiang, Xavier Nze Makanga, Ndong Atome Guy Roger and Louis-Clément Obame Engonga
    Citation: Egyptian Liver Journal 2024 14:55
  8. Echinococcosis, or hydatid disease, is caused by the larval forms of taeniid cestodes belonging to the genus Echinococcus. Echinococcus granulosus and E. multilocularis are the primary species responsible for hum...

    Authors: Mohamed Adam Mohamud, Abdirahman Ahmed Omar, Mohamed Hussein Adam, Arwa Elaagip and Ismail Gedi İbrahim
    Citation: Egyptian Liver Journal 2024 14:54
  9. Vasoactive intestinal peptide-secreting tumors (VIPomas), also known as WDHA syndrome (or “pancreatic cholera”), are rare neuroendocrine tumors (NETs) with an incidence of 0.05 to 2%. It secretes excessive amo...

    Authors: Gaurav Khatana, Lal Krishna Unnikrishnan, Sandesh Kolassery, Saji Sebastian, Sindhu Radha Sadasivan Nair and Ramu Muraleedharanpillai
    Citation: Egyptian Liver Journal 2024 14:53
  10. The approved screening test for HCV infection among blood donors is the HCV antibody test. The diagnostic performances of the available immunoassays in the market that target different HCV antigens have not ye...

    Authors: Dalia Diaa ElDine Salem and Heba-TAllah Nader ElSayed
    Citation: Egyptian Liver Journal 2024 14:51
  11. Chylous ascites (CA), an uncommon clinical condition, is defined as a milky-appearing, triglyceride-rich peritoneal fluid in the abdominal cavity. It may be due to malignancy or cirrhosis in developed countrie...

    Authors: Abdelmoneim Elhadidy, Mohamed Elrefaay, Hamdy Elsheshiny and Fathy Elnagdy
    Citation: Egyptian Liver Journal 2024 14:50
  12. This study aimed to determine the performance of AIMS65, Rockall score, and Glasgow-Blatchford score (GBS) in patients presenting with upper gastrointestinal bleeding (UGIB) and to compare results between pati...

    Authors: Gaurav Khatana, Sunil Kumar K, Sandesh Kolassery, Saji Sebastian, Deni Joseph, Ramu Muraleedharanpillai, Tony Joseph, Nithya V, Lal Krishna Unnikrishnan and Gino Rony
    Citation: Egyptian Liver Journal 2024 14:49
  13. The diagnosis and treatment of benign tumors of the gallbladder and bile ducts are difficult due to their anatomical relationships with neighboring vital organs. Hemangiomas are non-epithelial benign tumors of...

    Authors: F. Karahan, A. Atay, N. Ekinci and O. N. Dilek
    Citation: Egyptian Liver Journal 2024 14:48
  14. Endoscopic retrograde cholangiopancreatography (ERCP), a standard procedure used for diagnosing and treating pancreaticobiliary disorders, has the highest rate of complications among endoscopic procedures. We ...

    Authors: Fardad Ejtehadi, Iraj Shahramian, Mojtaba Khademi Befrouei, Gholam Reza Sivandzadeh, Seyed Alireza Taghavi, Ramin Niknam and Masoud Tahani
    Citation: Egyptian Liver Journal 2024 14:47
  15. Cholangiocarcinoma (CCA) is an aggressive malignancy with a poor prognosis of less than 20% five-year survival rate. Early diagnosis is typically challenging due to asymptomatic characteristics at the earliest...

    Authors: Ali Nada, Alzhraa Alkhatib, Fady Abdelmalik, Mona El-Abd, Naglaa S. Elabd and Hossam El-Din Abdel-Latif
    Citation: Egyptian Liver Journal 2024 14:46
  16. Hyperlipidemia is a vital etiology of acute pancreatitis (AP), 12 to 20% of which have a history of hyperlipidemia. Multiple organ failure is the major cause of the high mortality rate of AP. Liver injury has ...

    Authors: Jin-Ge Pan, Ru-Xue Qin, Xue-Ying Ma, Zi-Yu Han, Zhong-Hua Lu, Yun Sun and Wei-Li Yu
    Citation: Egyptian Liver Journal 2024 14:45
  17. In diseases characterized by fibrosis, hepatic stellate cells (HSCs) are mesenchymal cells that play an important role in liver fibrosis. circRNAs are involved in regulating hydatid exocyst formation through m...

    Authors: Baheti Kalifu, Yuan Meng, Zhi-Gang Ma, Chao Ma, Guang-Lei Tian, Jin-Guo Wang and Xiong Chen
    Citation: Egyptian Liver Journal 2024 14:44
  18. Nonalcoholic fatty liver disease (NAFLD) is a group of hepatic disorders ranging between simple form of accumulation of fat in hepatocytes (hepatic steatosis) and inflammation of liver internal tissues and inj...

    Authors: Ahmed Mohamed ElGhandour, Essam Mohammed Bayoumy, Moataz Mohammed Sayed, Moheb Sharaby Eskandaros, Abdelmomen Momen Mohamed Emam, Nahla Mohamed Teama, Manal Sabry Mohamed and Sonya Ahmed El-Gaaly
    Citation: Egyptian Liver Journal 2024 14:43
  19. Hepatic steatosis (HS) is a common and important histologic finding in patients with chronic hepatitis C virus (HCV) infection. However, little is known about this finding in HCV patients co-infected with huma...

    Authors: Aisha Elsharkawy, Shereen Abdel Alem, Saeed Moustafa, Shymaa Elnggar, Ahmed Cordie, Gamal Esmat and Ahmed Moustafa
    Citation: Egyptian Liver Journal 2024 14:42
  20. Hyponatremia portends a poor prognosis in decompensated cirrhosis and is an independent predictor of mortality. Multiple modalities have been evaluated in the management of hyponatremia, including albumin infu...

    Authors: Akash Roy, Suprabhat Giri, Sanchit Sharma, Surender Singh, Arka De, Prasun Jalal and Mahesh Goenka
    Citation: Egyptian Liver Journal 2024 14:41
  21. Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder that has been associated with an increased risk of cardiovascular diseases. Endothelial dysfunction, characterized by impaired flow-me...

    Authors: Nilesh Toke, Ajit Rathod, Pooja Phalak and Vikas Patel
    Citation: Egyptian Liver Journal 2024 14:40
  22. Acute liver failure (ALF) is a serious condition that refers to the development of synthetic function impairment after severe acute liver injury in an individual without pre-existing liver disease. Understandi...

    Authors: Nehad Sobhy Mansour, Behairy El-Sayed Behairy, Ahmad Mohamed Sira, Sally Waheed Elkhadry and Ola Ahmed Fouad
    Citation: Egyptian Liver Journal 2024 14:39
  23. Non-alcoholic fatty liver disease (NAFLD) is primarily perceived as a condition prevalent among obese individuals. Its pathogenesis is closely intertwined with metabolic syndrome components. However, the assoc...

    Authors: Meenu C. Nair, Lanord Stanley, Gisha Sivan and Janardanan Subramonia Kumar
    Citation: Egyptian Liver Journal 2024 14:38
  24. Hepatocellular carcinoma (HCC) is considered one of the most common cancers in the world and one of the principal causes of cancer-linked deaths. Therefore, identification of new biomarkers for diagnosis, espe...

    Authors: Eman Mohammed Helal, Sarah M. Shoeib and Shimaa Moustafa Mansour
    Citation: Egyptian Liver Journal 2024 14:37
  25. Hepatocellular carcinoma constitutes the most common primary hepatic cancer and remains a major medical burden in both developing and developed world. It ranks fifth in terms of global cases and second in term...

    Authors: Hany Samir Rasmy, Emad Ahmad Awad, Eslam Safwat Mohamed, Amal Samy Boshra, Shereen Abdel Monem Ibrahim and Amira Isaac
    Citation: Egyptian Liver Journal 2024 14:36
  26. HBV DNA assays have several limitations including being expensive and not widely available. Detection of HBsAg in serum has been the hallmark of HBV infection. However, previous studies regarding the associati...

    Authors: Ummi Maimunah, Puspa Wardhani, Citrawati Dyah Kencono Wungu, Anisa Firdausi Rahmanda, Andreas Agung Kurniawan and Andrio Palayukan
    Citation: Egyptian Liver Journal 2024 14:35
  27. Liver serves as a hub for key metabolic pathways such as folate cycle that provides one-carbon units for a network of metabolic reactions. Methylenetetrahydrofolate reductase (MTHFR) is a rate limiting enzyme ...

    Authors: Fatma Abozeid, Maysaa Zaki, Wafaa Nagah, Amany Ragab, Aya fathy, Dina Elhammady, Hayam Ghazy, Ahmed Yassen, Mohamed Serria, Omar Ammar, Maha Ragab and Manal Nomir
    Citation: Egyptian Liver Journal 2024 14:34
  28. Radiofrequency ablation (RFA) and microwave ablation (MWA) are widely accepted as the established treatment options for patients diagnosed with early-stage hepatocellular carcinoma (HCC) who are deemed unfit f...

    Authors: Mohamed Hassany, Ahmed Mostafa Mahboub, Wessam Mostafa, Hossam Debian, Hend Ibrahim Shousha and Magdy El-Serafy
    Citation: Egyptian Liver Journal 2024 14:33
  29. Mouth is the gateway to the total body wellness. Accordingly, oral microbiome influences overall health of an individual. Oral microbiome plays a key role in shaping up the host’s health profile. Obvious diffe...

    Authors: Maged Tharwat Elghannam, Moataz Hassan Hassanien, Yosry Abdelrahman Ameen, Emad Abdelwahab Turky, Gamal Mohammed ELattar, Ahmed Aly ELRay and Mohammed Darwish ELTalkawy
    Citation: Egyptian Liver Journal 2024 14:32
  30. Globally, MAFLD becomes in the top list of causes of liver disease. Its effect ranges from steatosis, metabolic steato-hepatitis to MAFLD-related cirrhosis and hepatocellular carcinoma. There is a growing evid...

    Authors: Eman Mahmoud Barakat, Iman Fawzy Montasser, Doaa Zakaria Zaky, Yasser Arafat Abdelrazik, Hoda Mohammed Farid, Ahmed El Dorry and Mohammed Kamal Shaker
    Citation: Egyptian Liver Journal 2024 14:30
  31. Osler-Weber-Rendu syndrome (OWRS) is an autosomal dominant disease with recurrent epistaxis, mucocutaneous telangiectasias, and arteriovenous malformations. Its clinical presentation ranges from simple skin le...

    Authors: ŞH Aktaş and S. Basat
    Citation: Egyptian Liver Journal 2024 14:29
  32. The human gut microbiota (GM) is a diverse ecosystem crucial for health, impacting physiological processes across the host's body. This review highlights the GM's involvement in Non-Alcoholic Fatty Liver Disea...

    Authors: Dinesh Mohan Swamikkannu, Santhosha Dasarapu, Rajendra Prasad Velivela Siva, Javali Nallam and Satvika Pabba
    Citation: Egyptian Liver Journal 2024 14:28
  33. Cyproheptadine is an easily available over-the-counter first-generation antihistaminic that is often used as an appetite stimulant. Although it is usually a safe drug, rare instances of drug-induced liver inju...

    Authors: Ayush Agarwal, Arpit Shastri, C. P. Ganesh, Malvika Shastri, Suvradeep Mitra, Debadrita Ray and Arka De
    Citation: Egyptian Liver Journal 2024 14:27
  34. Iron overload is a major problem in beta thalassemia patients due to repeated blood transfusions. The liver is the first organ to be loaded with iron. An accurate assessment of iron overload is necessary for m...

    Authors: Rohilla Seema, Chadha Kawaljeet Singh, Verma Anjali, Gill Paramjeet Singh, Yadav Alka and Singla Deepak
    Citation: Egyptian Liver Journal 2024 14:26
  35. Hepatocellular carcinoma is a major public health problem, as is considered the fastest growing cause of cancer-related death. Cannonball metastases as an initial finding in hepatocellular carcinoma are consid...

    Authors: Héctor Raúl Ibarra-Sifuentes, Gustavo Abraham Canales-Azcona, Jaqueline Isabel Gómez-Arredondo and Carlos Javier Rodríguez-Álvarez
    Citation: Egyptian Liver Journal 2024 14:25
  36. Eosinophilic ascites is non-common and challenging disease. This study aimed to describe the clinical presentation and treatment of eosinophilic ascites.

    Authors: Mohammed Ahmed Medhat, Mohamed O. Abdelmalek, Mohamed A. Mekky, Sherief Abd-Elsalam, Mohamed Ahmed Yehya Abdel-Malek, Sayed Hassan Ahmed, Yusuf S. Amry and Waleed Attia Hassan
    Citation: Egyptian Liver Journal 2024 14:24
  37. HBV infection is a significant concern in dialysis patients, influenced by various factors. This study aims to investigate the impact of serum uric acid levels on the immunogenicity of hepatitis Bvaccination i...

    Authors: Nasibe Golestani, Najmeh Shamspour, Jalal Azmandian, Habibeh Ahmadipour and Mahdi Karamipour zarei
    Citation: Egyptian Liver Journal 2024 14:23
  38. Obesity is a global health problem and has been increasing in Egypt over the last several decades. A national population screening program for hepatitis C included screening for obesity. Here we report the out...

    Authors: Gamal Esmat, Hala Zaid, Mohamed Hassany, Wael Abdel-Razek, Magdy El-Serafy, Wafaa El Akel, Aysam Salah, Ehab Kamal, Galal Elshishiney, Islam Ammar, Khaled Kabil, Mohamed AbdAllah, Ramy Saeed, Tarek Saad, Yasser Omar, Hany Dabbous…
    Citation: Egyptian Liver Journal 2024 14:22
  39. A prevalent liver condition called non-alcoholic fatty liver disease (NAFLD) may progress into non-alcoholic steatohepatitis (NASH) and cause life-threatening complications like cirrhosis and liver cancer. The...

    Authors: Pranali A. Jadhav, Asha B. Thomas, Rabindra K. Nanda and Sohan S. Chitlange
    Citation: Egyptian Liver Journal 2024 14:21
  40. Hepatic energy metabolism is intricately linked with the metabolic changes associated with HCV infection and hepatocellular carcinoma (HCC). This study investigated the potential of carnitine and acylcarnitine...

    Authors: Ashraf Abbass Basuni, Azza El Sheashaey, Ashraf El Fert, Manar Obada, Eman Abdelsameea, Mohamed Abdel-Samiee, Asmaa Ibrahim and Ashraf Khalil
    Citation: Egyptian Liver Journal 2024 14:19

    The Correction to this article has been published in Egyptian Liver Journal 2024 14:52

  41. NS5A inhibitors are an important option for treating chronic HCV-GT4 patients. Retreatments after NS5A-based DAAs failure are limited. We aimed to determine the effectiveness and safety of SOF/VEL-containing r...

    Authors: Heba Omar, Mohammed Hamdy Abdel Maksoud, Ahmed A. Goma, Essam A. Hassan, Nancy Abdalla Atta, Mahmoud Khalil, Mohamed Soliman Hegazy, Samy Zaky and Gamal Esmat
    Citation: Egyptian Liver Journal 2024 14:18
  42. Biliary atresia (BA) is an obliterative cholangiopathy of infancy that results in cholestasis and liver fibrosis. This fibrosis is due to an imbalance in extracellular matrix (ECM) breakdown and deposition. Th...

    Authors: Alif Abdelhakim Allam, Mohammed Ahmed Khedr, Shimaa Saad Elkholy, Takwa Abd El Rahman Yassin and Ola Ahmed Fouad
    Citation: Egyptian Liver Journal 2024 14:17
  43. Alterations of hemostasis in patients with decompensated cirrhosis are complex. Accordingly, standard coagulation tests are not feasible to evaluate bleeding risk in these patients. The aim of this study was t...

    Authors: Mona A. Abu El-Makarem, Aml A. Mohammad, Ola A. Afifi, Nehal I. Abbas, Tarek A. Abd El-Zaher, Safaa M. Abdel Halim and Aliaa S. Abd El-Fattah
    Citation: Egyptian Liver Journal 2024 14:16
  44. Liver fibrosis is an irreversible liver destruction. Apigenin (API) has different pharmacological properties as anticancer, anti-inflammatory, and antioxidant; however, API hepatoprotective and therapeutic eff...

    Authors: Zaenah Zuhair Alamri
    Citation: Egyptian Liver Journal 2024 14:15
  45. Chronic hepatitis C virus (HCV) infection negatively impacts health-related quality of life (HRQL). We aimed to assess patient-reported outcomes (PROs) to evaluate the impact of treating chronic HCV with direc...

    Authors: Mohamed Elbadry, Mahmoud Badawi, Naglaa Youssef, Martin Duracinsky, Shereen A. Saleh, Anna Funk, Hagar Elessawy, Eva Rumpler, Khadiga Sayed, Anca Vasiliu, Yoann Madec, Arnaud Fontanet and Mohamed El-Kassas
    Citation: Egyptian Liver Journal 2024 14:14
  46. Chronic hepatitis B virus (HBV) infection poses a significant global health challenge, impacting millions of individuals and elevating the risk of morbidity and mortality. Antiviral therapies are the primary t...

    Authors: Syed Ayaz Kazmi, Abdul Rauf, Muhammad Zahid Latif, Beenish Shahid, Sundus Khawaja and Zeeshan Anjum
    Citation: Egyptian Liver Journal 2024 14:13
  47. Liver cirrhosis (LC) advances from an asymptomatic phase (compensated cirrhosis) to a symptomatic phase (decompensated cirrhosis). Up to 80% of patients with LC may experience minimal hepatic encephalopathy (M...

    Authors: Essam S. Bedewy, Abeer Elhadidi, Naglaa Abd El-Latif, Yousra T. El Zawawy and Amany N. Abbasy
    Citation: Egyptian Liver Journal 2024 14:12

Official journal of

Egyptian Knowledge Bank (EKB) Journals

New Content Item (1)

Visit our collection of Egyptian journals.

Annual Journal Metrics

Citation Impact 2023
Journal Impact Factor: 0.8
5-year Journal Impact Factor: N/A
Source Normalized Impact per Paper (SNIP): 0.335
SCImago Journal Rank (SJR): 0.250

Speed 2023
Submission to first editorial decision (median days): 45
Submission to acceptance (median days): 158

Usage 2023
Downloads: 301,096
Altmetric mentions: 18